Clinical outcomes of penicillin skin testing

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 6, 2005, Pages 541-545

  Nadarajah, Kamalini ^a   Green, George R ^a   Naglak, Mary ^a  

^a ABINGTON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; IMIPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G SODIUM; PENICILLOYL POLYLYSINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; BACTERIUM CULTURE; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; ENTEROCOCCUS; FEVER; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; NAUSEA; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; RASH; RETROSPECTIVE STUDY; SKIN TEST; STAPHYLOCOCCUS AUREUS; TEACHING HOSPITAL; URTICARIA;

EID: 29444447627     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61016-2     Document Type: Article

References (25)

1. Arroliga ME, Wagner W, Bobek MB, et al. A pilot study of penicillin skin testing in patients with a history of penicillin allergy admitted to a medical ICU. Chest. 2000;118:1106-1108.
2. Malaman MF, Adkinson NF Jr. β-Lactams. In: Honsinger RW, Green GR, eds. Handbook of Drug Allergy. Philadelphia, PA: Williams & Wilkins; 2004:1-11.
3. Arroliga ME, Pien L. Penicillin allergy: consider trying penicillin again. Cleve Clin J Med. 2003;70:313-326.
4. Lee CE, Zembower TR, Fotis MA, et al. The incidence of antibiotic allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch Intern Med. 2000;160:2819-2822.
5. Arroliga ME, Radojicic C, Gordon SM, et al. A prospective observational study of the effect of penicillin skin testing on antibiotic use in the intensive care unit. Infect Control Hosp Epidemiol. 2003;24:347-350.
6. Gadde J, Spence M, Wheeler B, Adkinson NF Jr. Clinical experience with penicillin skin testing in a large inner-city STD clinic. JAMA. 1993;270:2456-2463.
7. Valyasevi MA, Van Dellen RG. Frequency of systematic reactions to penicillin skin tests. Ann Allergy Asthma Immunol. 2000;85:363-365.
8. Harris AD, Sauberman L, Kabbash L, et al. Penicillin skin testing: a way to optimize antibiotic utilization. Am J Med. 1999;107:166-168.
9. Solley GO, Gleich GJ, Van Dellen RG. Penicillin allergy: clinical experience with a battery of skin test reagents. J Allergy Clin Immunol. 1982;69:238-244.
10. Kelkar PS, Li JTC. Cephalosporin allergy. N Engl J Med. 2001;345:804-809.
11. Li JTC, Markus PJ, Osmon DR, et al. Reduction of vancomycin use in orthopedic patients with a history of antibiotic allergy. Mayo Clin Proc. 2000;75:902-906.
12. Cieslak PR, Strausbaugh LJ, Fleming DW, Ling JM. Vancomycin in Oregon: who's using it and why. Infect Control Hosp Epidemiol. 1999;20:557-560.
13. Tornieporth NG, Roberts RB, John J, et al. Risk factors associated with vancomycin resistant enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis. 1996;23:767-772.
14. Lautenbach E, Bilker WB, Brennan PJ. Enterococcal bacteremia: risk factors for vancomycin resistance and predictors of mortality. Infect Control Hosp Epidemiol. 1999;20:318-323.
15. Luber AD, Jacobs RA, Jordan M, Guglielmo BJ. Relative importance of oral versus intravenous vancomycin exposure in the development of vancomycin resistant enterococcus. J Infect Dis. 1996;173:1292-1293.
16. Lautenbach E, LaRosa LA, Marr AM, et al. Changes in the prevalence of vancomycin resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third generation cephalosporins. Clin Infect Dis. 2003;36:440-446.
17. Yehuda C, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin resistant enterococcus. Emerg Infect Dis. 2002;8:802-807.
18. Fridkin SK, Edwards JR, Courval JM, et al. The effect of vancomycin and third generation cephalosporin on prevalence of vancomycin resistant enterococcus in 126 US adult intensive care units. Ann Intern Med. 2001;135:175-183.
19. Salgado CD, Farr BM. Outcomes associated with vancomycin resistant enterococci: a meta analysis. Infect Control Hosp Epidemiol. 2003;24:690-698.
20. Scheid WM. Maintaining fluoroquinolone class efficacy: review of influencing factors. Emerg Infect Dis. 2003;9:1-9.
21. Solensky R, Earl HS, Gruchalla RS. Lack of penicillin resensitization in patients with a history of penicillin allergy after receiving repeated penicillin courses. Arch Intern Med. 2002;162:822-826.
22. Macy E, Mangat R, Burchette RJ. Penicillin skin testing in advance of need: multiyear follow-up in 568 test result-negative subjects exposed to oral penicillins. J Allergy Clin Immunol. 2003;111:1111-1115.
23. Pichichero ME, Pichichero DM. Diagnosis of penicillin, amoxicillin and cephalosporin allergy: reliability of examination by skin testing and oral challenge. J Pediatr. 1998;132:137-143.
24. Perencevich EN, Weller PF, Samore MH, Harris AD. Benefits of negative penicillin skin test results persists during subsequent hospital admissions. Clin Infect Dis. 2001;32:317-319.
25. Parker PJ, Parrinello JT, Condemi JJ, Rosenfeld SI. Penicillin resensitization among hospitalized patients. J Allergy Clin Immunol. 1991;88:213-217.